NEW YORK (GenomeWeb News) – The Lustgarten Foundation for Pancreatic Cancer said today it plans to launch a $1.25 million project to develop antibodies for biomarker targets for pancreatic cancer, the Foundation said today.
 
The Pancreatic Cancer Biomarker Development Project is a consortium of four research organizations including Canary Foundation, Dana-Farber Cancer Institute, University of California at San Francisco and Van Andel Research Institute.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.